Document:

Terms Document, dated as of March 17, 2005

 Exhibit 4.1 
  

CHASE ISSUANCE TRUST 
 as Issuer

  
 CLASS C(2005-1) TERMS DOCUMENT 
 dated as of March 17, 2005 
  
 to 
  
 AMENDED AND RESTATED 
 CHASESERIES INDENTURE SUPPLEMENT 
 dated as of October 15, 2004 
  
 to 
  
 AMENDED AND RESTATED 
 INDENTURE 
 dated as of October 15, 2004 
  
 WELLS FARGO BANK, NATIONAL ASSOCIATION 
 as Indenture Trustee and Collateral Agent 

 THIS CLASS C(2005-1) TERMS DOCUMENT (this “Terms Document”), by and between the CHASE ISSUANCE
TRUST, a statutory business trust created under the laws of the State of Delaware (the “Issuer”), having its principal office at c/o Wilmington Trust Company, 1100 North Market Street, Wilmington, Delaware 19890-1600, and WELLS FARGO BANK,
NATIONAL ASSOCIATION, a national banking association, as indenture trustee (the “Indenture Trustee”) and collateral agent (the “Collateral Agent”), is made and entered into as of March 17, 2005. 
  
 Pursuant to this Terms Document, the Issuer and the Indenture Trustee shall
create a new Tranche of CHASEseries Class C Notes and shall specify the principal terms thereof. 
  
 ARTICLE I 
  
 Definitions and Other Provisions of General Application 
  
 Section 1.01 Definitions. For all purposes of this Terms Document, except as otherwise expressly provided or unless the context otherwise requires: 
  
 (1) the terms defined in this Article have the meanings assigned to them in this Article, and include the plural as well as
the singular; 
  
 (2) all other terms used herein which are
defined in the Indenture Supplement, the Indenture or the Asset Pool Supplement, either directly or by reference therein, have the meanings assigned to them therein; 
  
 (3) as used in this Terms Document and in any certificate or other document made or delivered pursuant hereto or thereto,
accounting terms not defined in this Terms Document or in any such certificate or other document, and accounting terms partly defined in this Terms Document or in any such certificate or other document to the extent not defined, shall have the
respective meanings given to them under GAAP. To the extent that the definitions of accounting terms in this Terms Document or in any such certificate or other document are inconsistent with the meanings of such terms under GAAP, the definitions
contained in this Terms Document or in any such certificate or other document shall control; 
  
 (4) the words “hereof,” “herein,” “hereunder” and words of similar import when used in this Terms Document shall refer to this Terms Document as a whole and not to any particular
provision of this Terms Document; references to any subsection, Section, clause, Schedule or Exhibit are references to subsections, Sections, clauses, Schedules and Exhibits in or to this Terms Document unless otherwise specified; the term
“including” means “including without limitation”; references to any law or regulation refer to that law or regulation as amended from time to time and include any successor law or regulation; references to any Person include that
Person’s successors and assigns; and references to any agreement refer to such agreement, as amended, supplemented or otherwise modified from time to time; 

 (5) in the event that any term or provision contained herein shall conflict with or be inconsistent with
any term or provision contained in the Indenture Supplement, the Indenture or the Asset Pool Supplement, the terms and provisions of this Terms Document shall be controlling; and 
  
 (6) each capitalized term defined herein shall relate only to the Class C(2005-1) Notes and no other Tranche of CHASEseries
Notes issued by the Issuer. 
  
 “Asset Pool
Supplement” means the Amended and Restated Asset Pool One Supplement to the Indenture, dated as of October 15, 2004, among the Issuer, the Indenture Trustee and the Collateral Agent. 
  
 “BDL” means Banque de Luxembourg. 
  
 “Calculation Agent” is defined in Section 2.03(a).

  
 “Class C Reserve Account Percentage” means,
for any Monthly Period, (i) zero, if the Quarterly Excess Spread Percentage for such Monthly Period is greater than or equal to 4.50%, (ii) 1.50%, if the Quarterly Excess Spread Percentage for such Monthly Period is less than 4.50% and greater than
or equal to 4.00%, (iii) 2.00%, if the Quarterly Excess Spread Percentage for such Monthly Period is less than 4.00% and greater than or equal to 3.50%, (iv) 3.00%, if the Quarterly Excess Spread Percentage is less than 3.50% and greater than or
equal to 3.00%; (v) 4.00%, if the Quarterly Excess Spread Percentage for such Monthly Period is less than 3.00% and greater than or equal to 2.50%, (vi) 5.00%, if the Quarterly Excess Spread Percentage is less than 2.50% and greater than or equal to
2.00%, (vii) 6.00%, if the Quarterly Excess Spread Percentage for such Monthly Period is less than 2.00% and greater than or equal to 0.00% and (viii) 7.25%, if the Quarterly Excess Spread Percentage for such Monthly Period is less than 0.00%.

  
 “Class C(2005-1) Note” means any Note,
substantially in the form set forth in Exhibit A-3 to the Indenture Supplement, designated therein as a Class C(2005-1) Note and duly executed and authenticated in accordance with the Indenture. 
  
 “Class C(2005-1) Noteholder” means a Person in whose name a
Class C(2005-1) Note is registered in the Note Register. 
  
 “Class C(2005-1) Termination Date” means the earliest to occur of (a) the Principal Payment Date on which the Outstanding Dollar Principal Amount of the Class C(2005-1) Notes is paid in full, (b) the Legal Maturity Date and
(c) the date on which the Indenture is discharged and satisfied pursuant to Article V thereof. 
  
 “Controlled Accumulation Amount” means $35,416,666.67; provided, however, if the Accumulation Period Length is determined to be less than twelve months pursuant to Section 3.12(b)(ii) of
the Indenture Supplement, the Controlled Accumulation Amount for any Note Transfer Date with respect to the Class C(2005-1) Notes will be the amount specified in the definition of “Controlled Accumulation Amount” in the Indenture
Supplement. 

 “Indenture” means the Amended and Restated Indenture, dated as of October 15, 2004,
between the Issuer and the Indenture Trustee. 
  
 “Indenture Supplement” means the Amended and Restated CHASEseries Indenture Supplement, dated as of October 15, 2004, among the Issuer, the Indenture Trustee and the Collateral Agent. 
  
 “Initial Dollar Principal Amount” means $425,000,000.

  
 “Interest Payment Date” means April 15, 2005
and the 15th day of each month thereafter, or if such 15th day is not a Business Day, the next succeeding Business Day. 
  
 “Interest Period” means, with respect to any Interest Payment Date, the period from and including the previous Interest Payment Date (or
in the case of the initial Interest Payment Date, from and including the Issuance Date) to but excluding such Interest Payment Date. 
  
 “Issuance Date” means March 17, 2005. 
  
 “Legal Maturity Date” means November 15, 2012. 
  

“LIBOR” means, for any Interest Period, the London interbank offered rate for one-month United States dollar deposits determined by
the Trustee on the LIBOR Determination Date for each Interest Period in accordance with the provisions of Section 2.04. 
  
 “LIBOR Determination Date” means (1) March 15, 2005 for the period from and including the Issuance Date through but excluding April 15,
2005 and (2) for each interest period thereafter, the second London Business Day prior to the commencement of the second and each subsequent Interest Period. 
  
 “London Business Day” means any Business Day on which dealings in deposits in United States Dollars are transacted in the London
interbank market. 
  
 “Note Interest Rate” means
a rate per annum equal to 0.37% in excess of LIBOR as determined by the Calculation Agent on the related LIBOR Determination Date with respect to each Interest Period. 
  
 “Paying Agent” means Wells Fargo Bank, National Association. 
  
 “Predecessor Note” means, with respect to any particular
Note, every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purpose of this definition, any Note authenticated and delivered under Section 3.06 of the Indenture in lieu of a
mutilated, lost, destroyed or stolen Note shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note. 

 “Quarterly Excess Spread Percentage” means, for each Determination Date, the percentage
equivalent of a fraction the numerator of which is the sum of the Excess Spread Percentages with respect to the immediately preceding three Monthly Periods and the denominator of which is three. 
  
 “Record Date” means, for any Note Transfer Date, the last
Business Day of the preceding Monthly Period. 
  
 “Reference Banks” means four major banks in the London interbank market selected by the Beneficiary. 
  
 “Scheduled Principal Payment Date” means March 15, 2010. 
  
 “Stated Principal Amount” means $425,000,000. 
  
 “Telerate Page 3750” means the display page currently so designated on the Bridge Telerate Market Report
(or such other page as may replace that page on that service for the purpose of displaying comparable rates or prices). 
  
 Section 1.02 Governing Law. THIS TERMS DOCUMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF DELAWARE WITHOUT
REFERENCE TO ITS CONFLICT OF LAW PROVISIONS AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. 
  
 Section 1.03 Counterparts. This Terms Document may be executed in any number of counterparts, each of which so
executed will be deemed to be an original, but all such counterparts will together constitute but one and the same instrument. 
  
 Section 1.04 Ratification of Indenture and Indenture Supplement. As supplemented by this Terms Document, each of the Indenture, the Asset Pool
Supplement and the Indenture Supplement is in all respects ratified and confirmed and the Indenture as so supplemented by the Asset Pool Supplement and the Indenture Supplement as so supplemented by this Terms Document shall be read, taken and
construed as one and the same instrument. 
  
 [END OF ARTICLE I]

 ARTICLE II 
  
 The Class C(2005-1) Notes 
  
 Section 2.01 Creation and Designation. There is hereby created a Tranche of CHASEseries Class C Notes to be issued pursuant to the Indenture and
the Indenture Supplement to be known as the “CHASEseries Class C(2005-1) Notes.” 
  
 Section 2.02 Interest Payment. 
  
 (a) For each Interest Payment Date, the amount of interest due with respect to the Class C(2005-1) Notes shall be an amount equal to the product of (i)(A) a fraction, the numerator of which is the actual number of days in the related
Interest Period and the denominator of which is 360, times (B) the Note Interest Rate in effect with respect to the related Interest Period, times, (ii) the Outstanding Dollar Principal Amount of the Class C(2005-1) Notes determined as
of the close of business on the Interest Payment Date preceding the related Note Transfer Date for the Class C(2005-1) Notes; provided, however, that for the first Interest Payment Date the amount of interest due with respect to the
Class C(2005-1) Notes shall be an amount equal to the product of (x) the Outstanding Dollar Principal Amount of the Class C(2005-1) Notes on the Issuance Date, (y) 29 divided by 360 and (z) the Note Interest Rate in effect with respect to the Class
C(2005-1) Notes determined on March 15, 2005. Interest on the Class C(2005-1) Notes will be calculated on the basis of the actual number of days elapsed and a 360-day year. 
  
 (b) Pursuant to Section 3.03 of the Indenture Supplement, on each Note Transfer Date with respect to the Class C(2005-1)
Notes, the Indenture Trustee shall deposit into the Class C(2005-1) Interest Funding Sub-Account the portion of CHASEseries Available Finance Charge Collections allocable to the Class C(2005-1) Notes. 
  
 Section 2.03 Calculation Agent; Determination of LIBOR. 
  
 (a) The Issuer hereby agrees that for so long as any Class C(2005-1) Notes
are Outstanding, there shall at all times be an agent appointed to calculate LIBOR for each Interest Period (the “Calculation Agent”). The Issuer hereby initially appoints the Indenture Trustee as the Calculation Agent for purposes of
determining LIBOR for each Interest Period. The Calculation Agent may be removed by the Issuer at any time. If the Calculation Agent is unable or unwilling to act as such or is removed by the Issuer, or if the Calculation Agent fails to determine
LIBOR for an Interest Period, the Issuer shall promptly appoint a replacement Calculation Agent that does not control or is not controlled by or under common control with the Issuer or its Affiliates. The Calculation Agent may not resign its duties,
and the Issuer may not remove the Calculation Agent, without a successor having been duly appointed. 
  
 (b) On each LIBOR Determination Date, the Calculation Agent shall determine LIBOR on the basis of the rate for deposits in United States dollars for a
one-month period which appears on Telerate Page 3750 or on such comparable system as 

 is customarily used to quote LIBOR as of 11:00 a.m., London time, on such date. If such rate does not appear on Telerate
Page 3750 or on a comparable system as is customarily used to quote LIBOR the rate for that LIBOR Determination Date shall be determined on the basis of the rates at which deposits in United States dollars are offered by the Reference Banks at
approximately 11:00 a.m., London time, on that day to prime banks in the London interbank market for a one-month period. The Calculation Agent shall request the principal London office of each of the Reference Banks to provide a quotation of its
rate. If at least two such quotations are provided, the rate for that LIBOR Determination Date shall be the arithmetic mean of the quotations. If fewer than two quotations are provided as requested, the rate for that LIBOR Determination Date will be
the arithmetic mean of the rates quoted by major banks in New York City, selected by the Beneficiary, at approximately 11:00 a.m., New York City time, on that day for loans in United States dollars to leading European banks for a one-month period.

  
 (c) The Note Interest Rate applicable to the then current and
the immediately preceding Interest Periods may be obtained by telephoning the Indenture Trustee at its corporate trust office at (612) 667-8058 or such other telephone number as shall be designated by the Indenture Trustee for such purpose by prior
written notice by the Indenture Trustee to each Noteholder from time to time. 
  
 (d) On each LIBOR Determination Date, the Calculation Agent shall send to the Indenture Trustee and the Beneficiary, by facsimile transmission, notification of LIBOR for the following Interest Period. 
  
 Section 2.04 Payments of Interest and Principal. 
  
 (a) Any installment of interest or principal, if any, payable on any Class
C(2005-1) Note which is punctually paid or duly provided for by the Issuer and the Indenture Trustee on the applicable Interest Payment Date or Principal Payment Date shall be paid by the Paying Agent to the Person in whose name such Class C(2005-1)
Note (or one or more Predecessor Notes) is registered on the Record Date, by wire transfer of immediately available funds to such Person’s account as has been designated by written instructions received by the Paying Agent from such Person not
later than the close of business on the third Business Day preceding the date of payment or, if no such account has been so designated, by check mailed first-class, postage prepaid to such Person’s address as it appears on the Note Register on
such Record Date, except that with respect to Notes registered on the Record Date in the name of the nominee of Cede & Co., payment shall be made by wire transfer in immediately available funds to the account designated by such nominee.

  
 (b) The right of the Class C(2005-1) Noteholders to receive
payments from the Issuer will terminate on the first Business Day following the Class C(2005-1) Termination Date. 
  
 Section 2.05 Targeted Amount to be on Deposit in the Class C Reserve Sub-Account. The amount targeted, with respect to any Monthly Period, to be on
deposit in the Class C Reserve Sub-Account for the Class C(2005-1) Notes on the Note Transfer 

 Date in the immediately succeeding Monthly Period, will, on the issuance date, be zero and, thereafter, will be an amount
equal to the product of (A) the Class C Reserve Account Percentage for such Monthly Period times (B) the Initial Outstanding Dollar Principal Amount of the CHASEseries Notes (exclusive of (x) any Class or Tranche of CHASEseries Notes which will be
paid in full on the applicable Payment Date for such Class or Tranche of CHASEseries Notes in the immediately succeeding Monthly Period and (y) any Class or Tranche of CHASEseries Notes which will have a Nominal Liquidation Amount of zero on the
applicable Payment Date for such Class or Tranche of CHASEseries Notes in the immediately succeeding Monthly Period) times (C) a fraction, the numerator of which is the Nominal Liquidation Amount of the Class C(2005-1) Notes as of the close of
business on the last day of such Monthly Period (exclusive of the amount deposited with respect to the Targeted Principal Deposit Amount on the applicable Note Transfer Date for such Tranche of CHASEseries Class C Notes in the next succeeding
Monthly Period) and the denominator of which is the Nominal Liquidation Amount of all Class C Notes in the CHASEseries as of the close of business on the last day of such Monthly Period (exclusive of the amount deposited with respect to the Targeted
Principal Deposit Amount on the applicable Note Transfer Date for all Tranches of CHASEseries Class C Notes in the next succeeding Monthly Period); provided however, that if an Early Redemption Event or Event of Default occurs with respect to the
Class C(2005-1) Notes, the amount targeted to be on deposit will be the Initial Outstanding Dollar Principal Amount of the Class C(2005-1) notes. 
  
 The Issuer may change the percentage and methodology set forth above for calculating the amount targeted to be on deposit in the Class C Reserve
Sub-Account for the Class C(2005-1) Notes without the consent of any Noteholder so long as the Issuer has (i) received written confirmation from each Note Rating Agency that has rated any Outstanding Notes of the CHASEseries that the change in such
percentage or formula will not result in a Ratings Effect with respect to any Outstanding Class C(2005-1)Notes and (ii) delivered to the Indenture Trustee and the Note Rating Agencies a Master Trust Tax Opinion and an Issuer Tax Opinion. 

 
 Section 2.06 Form of Delivery of Class C(2005-1) Notes; Depository;
Denominations. 
  
 (a) The Class C(2005-1) Notes shall each
be delivered in the form of a global Registered Note as provided in Sections 2.02 and 3.01(i) of the Indenture, respectively. 
  
 (b) The Depository for the Class C(2005-1) Notes shall be The Depository Trust Company, and the Class C(2005-1) Notes shall initially be registered in
the name of Cede & Co., its nominee. 
  
 (c) The Class
C(2005-1) Notes will be issued in minimum denominations of $1,000 and integral multiples of that amount. 

 Section 2.07 Delivery and Payment for the Class C(2005-1) Notes. The Issuer shall execute and
deliver the Class C(2005-1) Notes to the Indenture Trustee for authentication, and the Indenture Trustee shall deliver the Class C(2005-1) Notes when authenticated, each in accordance with Section 3.03 of the Indenture. 
  
 Section 2.08 Supplemental Indenture. The Issuer may enter into a
supplemental indenture with respect to the Class C(2005-1) Notes as provided in Section 9.01 of the Indenture; provided, however, that any supplemental indenture which provides for an additional or alternative form of credit
enhancement for the Class C(2005-1) Notes shall, in addition to the requirements set forth in Section 9.01 of the Indenture, require confirmation from the Note Rating Agencies that have rated any Outstanding Notes of the CHASEseries that such change
in credit enhancement will not result in a Ratings Effect with respect to any Outstanding Notes of the CHASEseries. 
  
 Section 2.09 Appointment of co-Paying Agent and co-Transfer Agent. BDL is appointed as co-paying agent and as co-transfer agent in Luxembourg with
respect to the Class C(2005-1) Notes for so long as the Class C(2005-1) Notes are listed on the Luxembourg Stock Exchange. Any reference in this Terms Document, the Indenture Supplement, the Asset Pool Supplement and the Indenture to the Paying
Agent or the Transfer Agent shall be deemed to include BDL as co-paying agent or co-transfer agent, as the case may be, unless the context requires otherwise. 
  

[END OF ARTICLE II] 

 IN WITNESS WHEREOF, the parties hereto have caused this Terms Document to be duly executed, all as of the
day and year first above written. 
  

			
	CHASE ISSUANCE TRUST
		
	By:	 	CHASE BANK USA,
	 	 	NATIONAL ASSOCIATION
	 	 	(formerly known as Chase Manhattan Bank USA, National Association),
	 	 	as Beneficiary and not in its individual capacity
		
	By:	 	 /s/ Keith W. Schuck

	Name:	 	Keith W. Schuck
	Title:	 	President
	
	WELLS FARGO BANK, NATIONAL
	ASSOCIATION, as Indenture Trustee and Collateral Agent
		
	By:	 	 /s/ Cheryl C. Zimmerman

	Name:	 	Cheryl C. Zimmerman, CCTS
	Title:	 	Assistant Vice President

  
 Signature Page to
the Chase Issuance Trust 
 CHASEseries Class C(2005-1) Terms Document 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	PAGE

		
	ARTICLE I Definitions and Other Provisions of General Application	  	 
			
	 Section 1.01
	  	 Definitions
	  	1
	 Section 1.02
	  	 Governing Law
	  	4
	 Section 1.03
	  	 Counterparts
	  	4
	 Section 1.04
	  	 Ratification of Indenture and Indenture Supplement
	  	4
		
	ARTICLE II The Class C(2005-1) Notes	  	 
			
	 Section 2.01
	  	 Creation and Designation
	  	5
	 Section 2.02
	  	 Interest Payment
	  	5
	 Section 2.03
	  	 Calculation Agent; Determination of LIBOR
	  	5
	 Section 2.04
	  	 Payments of Interest and Principal
	  	6
	 Section 2.05
	  	 Targeted Amount to be on Deposit in the Class C Reserve Sub-Account
	  	6
	 Section 2.06
	  	 Form of Delivery of Class C(2005-1) Notes; Depository; Denominations
	  	7
	 Section 2.07
	  	 Delivery and Payment for the Class C(2005-1) Notes
	  	8
	 Section 2.08
	  	 Supplemental Indenture
	  	8
	 Section 2.09
	  	 Appointment of co-Paying Agent and co-Transfer Agent
	  	8

  

 iWarrant, dated September 4, 2001, issued to Accenture plc.

 Exhibit 4.9 
  

THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 
  
 CHORDIANT SOFTWARE, INC. 
  
 WARRANT TO PURCHASE COMMON STOCK 
  

			
	No. AW-1	 	September 4, 2001

  
 Void After September
4, 2006 
  
 THIS CERTIFIES
THAT, for value received, Accenture plc, a company registered in Gibraltar with registered number 79571, having its principal office at 60 Queen Victoria Street, London EC4N 4TW, UK (“Accenture”), or
assigns (Accenture and its assignee shall be referred to herein as the “Holder”), is eligible to subscribe for and purchase at the Exercise Price (defined below) from CHORDIANT SOFTWARE,
INC., a Delaware corporation, with its principal office at 20400 Stevens Creek Blvd., Suite 400, Cupertino, CA 95014, USA (the “Company”) up to Six Hundred Thousand (600,000) shares of the common stock of the Company
(the “Common Stock”), in accordance with the vesting schedule in Section 2.2 hereof. 
  
 1. DEFINITIONS. Unless otherwise defined herein all capitalized terms shall have the meanings set forth in the Joint Marketing and Strategic Alliance Agreement of even date hereof between
Accenture and the Company (the “Strategic Alliance Agreement”). As used herein, the following terms shall have the following respective meanings: 
  
 (a) “Acceptable Alliance Revenues” means the amount of gross license fee revenues received by the Company for Chordiant
Sales Referrals less (i) the aggregate dollar value of all discounts to the Company’s list price for the Software, on such Chordiant Sales Referral and (ii) the aggregate amount of all payments to Accenture and its Affiliates, including without
limitation, all payments of referral fees pursuant to the Revenue Share Schedule, under the terms of the Strategic Alliance Agreement. Notwithstanding the foregoing, for purposes of the calculation of “Acceptable Alliance Revenues”: (x)
any individual Chordiant Sales Referral that results in Two Million Dollars ($2,000,000) or less in license fee revenues received by the Company (net of all discounts, amounts paid to Accenture under the terms of the Strategic Alliance Agreement
attributable to such Chordiant Sales Referral, and cancellations and refunds attributable thereto) shall be excluded from the calculation of Acceptable Alliance Revenues and (y) any individual Chordiant Sales Referral that results in more than Ten
Million Dollars ($10,000,000) in license fee revenues (net of all discounts, amounts paid to Accenture under the 

  

 
terms of the Strategic Alliance Agreement attributable to such Chordiant Sales Referral, and cancellations and refunds attributable thereto) shall be deemed
to be a Chordiant Sales Referral equal in amount to Ten Million Dollars ($10,000,000). 
  
 (b) “Affiliate” means any entity, whether incorporated or not, that is controlled by or is under common control with
Accenture Ltd, a Bermudan holding company. 
  
 (c) “Chordiant Sales Referral” means a license of the Software to an end user who is a joint Accenture/Chordiant prospect (as determined in accordance with Section 4.2.2 of the Strategic Allianace Agreement) in such
territory initially specified in the Strategic Alliance Agreement, such joint Accenture/Chordiant prospect as confirmed in the Prospect Tracking Tool (all as set forth in Section 4.2.2 of the Strategic Alliance Agreement). 
  
 (d) “Exercise Period” means the period
commencing with the date hereof and ending on the Expiration Date. 
  
 (e) “Exercise Price” means the amount equal to (i) the closing price per share of the Common Stock (as reported in the Wall Street Journal) on the date of execution of this Warrant multiplied
by (ii) 2.5. 
  
 (f) “Exercise
Shares” means the shares of the Company’s Common Stock issuable upon exercise of this Warrant. 
  
 (g) “Expiration Date” shall mean the date five (5) years after the date of this Warrant above. 
  
 (h) “Sale of the Company” means a merger or
consolidation of the Company with or into any other entity or a sale of stock of the Company, in which the stockholders of this Company immediately before the merger or stock sale do not hold more than 50% of the voting power of the surviving
corporation immediately after the merger or stock sale, or a sale, conveyance or disposition of substantially all of the assets.  
  
 (i) “Vesting Period” means the period from the date hereof until September 4, 2003. 
  
 2. EXERCISE OF WARRANT.
The rights represented by this Warrant may be exercised in whole or in part at any time during the Exercise Period to the extent vested in accordance with Section 2.2 below, by delivery of the following to the Company at its address set forth above
(or at such other address as it may designate by notice in writing to the Holder): 
  
 (a) An executed Notice of Exercise in the form attached hereto; 
  
 (b) Payment of the Exercise Price in cash or by check or wire transfer (subject to Section 2.1
hereof); and 
  
 (c) This Warrant.

  
 Upon the exercise of the rights represented by this Warrant, a
certificate or certificates for the Exercise Shares so purchased, registered in the name of the Holder or persons Affiliated with 

  

 2. 

 
the Holder, if the Holder so designates, shall be issued and delivered to the Holder within a reasonable time after the rights represented by this Warrant
shall have been so exercised. 
  
 The person in whose name any
certificate or certificates for Exercise Shares are to be issued upon exercise of this Warrant shall be deemed to have become the holder of record of such shares on the date on which this Warrant was surrendered and payment of the Exercise Price was
made, irrespective of the date of delivery of such certificate or certificates, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the
holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open. 
  
 2.1. Net Exercise. Notwithstanding any provisions herein to the contrary, if the fair market value of one share of Common Stock is greater
than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, the Holder may at its option elect to receive Exercise Shares equal to the value (as determined below) of this Warrant
(or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company shall issue to the Holder a number of shares of Common
Stock computed using the following formula: 
  

					
	 X =
	 	Y (A-B)	  	 
	 	 	A	  	 

  

					
	 Where
	  	X =	  	the number of shares of Exercise Shares to be issued to the Holder
			
	 	  	Y =	  	the number of shares of Exercise Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such
calculation)
			
	 	  	A =	  	the fair market value of one share of the Company’s Exercise Shares (at the date of such calculation)
			
	 	  	B =	  	Exercise Price (as adjusted to the date of calculation)

  
 For purposes of the
above calculation, the fair market value of one Exercise Share shall mean the arithmetic average of the closing sales prices of the Common Stock quoted on a stock exchange or the arithmetic average of the bid and asked prices of the Common Stock in
such over-the-counter market in which the Common Stock may be traded, whichever is applicable, for the 20 consecutive trading days (or such shorter period of time as the Common Stock is actually traded on such stock exchange and/or the
over-the-counter market) immediately preceding the relevant date of exercise of the Warrant, as reported in the Wall Street Journal; or (ii) if the Common Stock has not been traded on either a stock exchange or on the over-the-counter market
at any time during the 20 consecutive business days immediately prior to the date of such calculation, the price determined in good faith by the Company’s Board of Directors. 
  

 3. 

 2.2. Vesting Schedule. This Warrant shall vest and become exercisable on the last day of
each such fiscal quarter for such number of Exercise Shares equal to the quotient obtained by dividing (a) the amount of Acceptable Accenture Revenues earned in such fiscal quarter of the Company (or the applicable portion of the fiscal quarter)
during the Vesting Period by (b) 60; provided, that notwithstanding the foregoing, in no event shall the aggregate number of Exercise Shares for which this Warrant may vest and be exercised pursuant to this Section 2.2(a) exceed Six Hundred Thousand
(600,000). For the avoidance of doubt, it is acknowledged and agreed that all Exercise Shares which do not vest pursuant to this Section 2.2 shall remain unvested. 
  
 3. COVENANTS OF THE COMPANY. 
  
 3.1. Covenants as to Exercise Shares. The Company covenants
and agrees that all Exercise Shares that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with
respect to the issuance thereof. The Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from preemptive rights, a sufficient number of shares of its Common Stock to
provide for the exercise of the rights represented by this Warrant. If at any time during the Exercise Period the number of authorized but unissued shares of Common Stock shall not be sufficient to permit exercise of this Warrant, the Company will
take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes. 
  
 3.2. No Impairment. Except and to the extent as waived or
consented to by the Holder, the Company will not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of
all such action as may be necessary or appropriate in order to protect the exercise rights of the Holder against impairment. 
  
 4. REPRESENTATIONS OF HOLDER. 
  
 4.1. Acquisition of Warrant for Personal Account. The Holder represents and warrants that it is acquiring the
Warrant solely for its account for investment and not with a view to or for sale or distribution of said Warrant or any part thereof. The Holder also represents that the entire legal and beneficial interests of the Warrant and Exercise Shares the
Holder is acquiring is being acquired for, and will be held for, its account only. 
  
 4.2. Securities Are Not Registered. 
  
 (a) The Holder understands that the Warrant and the Exercise Shares have not been registered under the Securities Act of 1933, as
amended (the “Act”) on the basis that no distribution or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be present if, notwithstanding its representations, the
Holder has a present intention of acquiring the securities for a fixed or determinable period in the 

  

 4. 

 
future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing the securities. The Holder has no
such present intention. 
  
 (b) The Holder
recognizes that the Warrant and the Exercise Shares must be held indefinitely unless they are subsequently registered under the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to
register the Warrant or the Exercise Shares of the Company, or to comply with any exemption from such registration. 
  
 (c) The Holder is aware that neither the Warrant nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the Act
unless certain conditions are met, including, among other things, the resale following the required holding period under Rule 144 and the number of shares being sold during any three month period not exceeding specified limitations. 
  
 4.3. Information and Sophistication. The Holder acknowledges
that it has received all the information it has requested from the Company and it considers necessary or appropriate for deciding whether to acquire the Securities. The Holder represents that it has had an opportunity to ask questions and receive
answers from the Company regarding the terms and conditions of the offering of the Securities and to obtain any additional information necessary to verify the accuracy of the information given the Purchaser. The Holder further represents that it has
such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risk of this investment. 
  
 4.4. Ability to Bear Economic Risk. The Holder acknowledges that investment in the Securities involves a high degree of risk, and represents
that it is able, without materially impairing its financial condition, to hold the Securities for an indefinite period of time and to suffer a complete loss of its investment. 
  
 4.5. Disposition of Warrant and Exercise Shares. 
  
 (a) The Holder further agrees not to make any
disposition of all or any part of the Warrant or Exercise Shares in any event unless and until: 
  
 (i) The Company shall have received a letter secured by the Holder from the U.S. Securities and Exchange Commission stating that no
action will be recommended to the Commission with respect to the proposed disposition; or 
  
 (ii) There is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made
in accordance with said registration statement; or 
  
 (iii) The Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the
Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, for the Holder to the effect that such disposition will not require registration of such Warrant or Exercise Shares under the
Act or any applicable state securities laws. 
  

 5. 

 (b) The Holder understands and agrees that all certificates evidencing the shares
to be issued to the Holder may bear the following legend: 
  
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE
SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 
  
 4.6. Accredited Investor Status. The Holder represents that it is an “accredited investor” as such term is defined in Rule 501
under the Act. 
  
 4.7. Further Assurances. The
Holder agrees and covenants that at any time and from time to time it will promptly execute and deliver to the Company such further instruments and documents and take such further action as the Company may reasonably require in order to carry out
the full intent and purpose of this Warrant. 
  
 5.
ADJUSTMENT OF EXERCISE PRICE. In the event of changes in the outstanding Common Stock of the Company by reason of stock dividends, splits, reverse splits, recapitalizations,
reclassifications or the like, the number and class of shares available under the Warrant in the aggregate and the Exercise Price shall be correspondingly adjusted to give the Holder of the Warrant, on exercise for the same aggregate Exercise Price,
the total number, class, and kind of shares as the Holder would have owned had the Warrant been exercised prior to the event and had the Holder continued to hold such shares until after the event requiring adjustment; provided, however, that such
adjustment shall not be made with respect to, and this Warrant shall terminate if not exercised prior to, the events set forth in Section 7 below. The form of this Warrant need not be changed because of any adjustment in the number of Exercise
Shares subject to this Warrant. 
  
 6.
FRACTIONAL SHARES. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this
Warrant may be aggregated for purposes of determining whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of
issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product resulting from multiplying the then current fair market value of an Exercise Share by such fraction. 
  
 7. EARLY TERMINATION. In the event of,
at any time prior to the end of the Exercise Period, the Sale of the Company, the Company shall provide to the Holder twenty (20) days advance written notice of such Sale of the Company, and this Warrant shall terminate unless fully exercised prior
to the occurrence of such Sale of the Company. 
  

 6. 

 8. NO STOCKHOLDER RIGHTS. This Warrant in and of
itself shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. 
  
 9. TRANSFER OF WARRANT. This Warrant is related to the unique services provided to the Company by the
Holder and therefore this Warrant and all rights hereunder may not be transferred, sold or assigned in any way, including any transfer by operation of law and any attempted transfer will be void and of no effect. Notwithstanding the foregoing,
Accenture may assign, sell or transfer this Warrant to an Affiliate provided that it provides prior written notification to the Company in the form of assignment attached hereto and provided that such assignment, sale or transfer complies in full
with all applicable laws, rules and regulations, including without limitation U.S. securities laws. 
  
 10. LOST, STOLEN, MUTILATED OR DESTROYED WARRANT. If this
Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like
denomination and tenor as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall
be at any time enforceable by anyone. 
  
 11.
NOTICES, ETC. All notices and other communications required or permitted hereunder shall be in writing and shall be sent by facsimile transmission, express mail or other form of rapid
communications, if possible, and if not then such notice or communication shall be mailed by first-class mail, postage prepaid, addressed in each case to the party entitled thereto at the following addresses: (a) if to the Company, to Chordiant
Software, Inc., 20400 Stevens Creek Blvd., Suite 400, Cupertino, CA 95014, Attention: President and (b) if to the Holder, to Accenture plc, 60 Queen Victoria Street, London EC4N 4TW, UK, Attention:
                     or at such other address as one party may furnish to the other in writing. Notice shall be deemed effective on the date
dispatched if by personal delivery or facsimile transmission, two days after mailing if by express mail, or three days after mailing if by first-class mail. 
  
 12. VALUE ADDED TAX. For the avoidance of doubt, the Company shall pay any value added tax payable in
respect of the grant of this Warrant to the Holder and the value received by the Company for such grant. Any such tax shall be paid within 30 days of receipt of a value added tax invoice. 
  
 13. ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to
all of the terms and conditions contained herein. 
  
 14.
GOVERNING LAW. This Warrant and all rights, obligations and liabilities hereunder shall be governed by the laws of the State of California. 
  

 7. 

 IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its duly authorized officer as of September 4, 2001. 
  

			
	CHORDIANT SOFTWARE, INC .
		
	By:	 	/s/    STEVE G. VOGEL
	 	 	 

  

 8. 

  
 NOTICE OF EXERCISE

  
 TO: CHORDIANT SOFTWARE,
INC. 
  
 (1)  ̈ The undersigned hereby elects to purchase                      shares of
the Common Stock of Chordiant Software, Inc. (the “Company”) pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. 

 
  ̈ The undersigned hereby elects to purchase                      shares of the
Common Stock of Chordiant Software, Inc. (the “Company”) pursuant to the terms of the net exercise provisions set forth in Section 2.1 of the attached Warrant, and shall tender payment of all applicable transfer taxes, if any.

  
 (2) Please issue a certificate or certificates representing
said shares of Common Stock in the name of the undersigned or in such other name as is specified below: 
  
 __________________________________ 
 (Name) 
  
 __________________________________ 
  
 __________________________________ 
 (Address) 
  
 (3) The undersigned represents that (i) the aforesaid shares of Common Stock are being acquired for the account of the undersigned for investment and not
with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares; (ii) the undersigned is aware of the Company’s business affairs and financial
condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding its investment in the Company; (iii) the undersigned is experienced in making investments of this type and has such
knowledge and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment and protecting the undersigned’s own interests; (iv) the undersigned understands that the shares of
Common Stock issuable upon exercise of this Warrant have not been registered under the Securities Act of 1933, as amended (the “Act”), by reason of a specific exemption from the registration provisions of the Act, which exemption depends
upon, among other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered under the Act, they must be held indefinitely unless subsequently registered under the Act or an
exemption from such registration is available; (v) the undersigned is aware that the aforesaid shares of Common Stock may not be sold pursuant to Rule 144 adopted under the Act unless certain conditions are met and until the undersigned has held the
shares for the number of years prescribed by Rule 144; and (vi) the undersigned agrees not to make any disposition of all or any part of the aforesaid shares of Common Stock unless and until there is then in effect a registration statement under the
Act covering such proposed disposition and such disposition is made in accordance with said registration statement, or the undersigned has provided the Company with an opinion of counsel satisfactory to the Company, stating that such registration is
not required. 
  

					
			
	  	 	 	 	  
	 (Date)
	 	 	 	 (Signature)

			
	  	 	 	 	  
	 	 	 	 	 (Print name)

  

  
 ASSIGNMENT FORM

  

					
	 	 	 (To assign the foregoing Warrant, execute
 this form and supply required information.
 Do not use this form to purchase shares.)
	  	 

  
 FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to 
  

							
	Name:	  	 	  	 	  	 
	 	  	(Please Print)
				
	Address: 	  	 	  	 	  	 
	 	  	(Please Print)
				
	Dated:	  	 	  	 	  	 
				
	Holder’s Signature:	  	 	  	 	  	 
				
	Holder’s Address: 	  	 	  	 	  	 

  
 NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file
proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]